For many startups, the most difficult capital raise is not venture capital financing. It is the first one million dollars. Institutional investors rarely provide the first check. Most venture funds prefer to invest after a company has demonstrated product development, customer validation, industry traction, revenue growth, or some combination of operational milestones. Founders therefore face an initial challenge: how to assemble sufficient capital, credibility, and market support to become investable in the first place.
Too often, founders treat financing documents as financing strategies. A SAFE (Simple Agreement for Future Equity), convertible note, or common stock financing may provide a mechanism through which capital can be invested. Still, none of those instruments independently answers the more important question of why an investor should invest.
Traditional financing instruments such as SAFEs, convertible notes, and Regulation D offerings remain important tools for raising capital from passive investors and more conventional angel participants. At the same time, companies may benefit from a parallel strategy that focuses less on immediate capital formation and more on building long-term investor conviction by engaging experienced industry participants who become familiar with the business through advisory relationships before making investment decisions.
Rather than approaching investors as strangers, the company first develops relationships with experienced industry participants who become familiar with the business through advisory engagement. Over time, some of those advisors may independently decide to invest. Those investors may then be granted contractual opportunities to increase their investment as the company executes against its business plan. Properly structured, this sequence can create a practical roadmap toward a company’s first meaningful capital raise while maintaining clear separation between compensatory equity arrangements and investment transactions.
The framework begins with confidentiality, progresses to advisory participation, advances to direct investment, and ultimately establishes a mechanism by which investors can commit substantially larger amounts of capital over time. The objective is not merely to raise money, but to transform industry expertise and business credibility into future capital formation.
The first stage involves a nondisclosure agreement. Before discussing proprietary technology, customer relationships, growth strategies, product development plans, financing objectives, or other sensitive business information, the company enters into a confidentiality arrangement with prospective advisors. Although frequently overlooked, this stage serves an important function. It allows the company to candidly discuss its opportunities and challenges while enabling the prospective advisor to evaluate the business in a setting that is not yet focused on capital raising.
If the parties determine that a deeper relationship is appropriate, the company may enter into a written advisory agreement pursuant to which the advisor provides bona fide strategic, operational, technical, commercial, or industry-specific services. Compensation may consist, in whole or in part, of stock options or other forms of compensatory equity. Those awards should be tied to legitimate services provided to the company and drafted with clearly defined vesting conditions, performance objectives, confidentiality obligations, intellectual property provisions, and termination mechanics. In many cases, the equity may be structured in reliance on Rule 701 under the Securities Act of 1933, reflecting that the securities are being issued for compensatory purposes rather than as part of a capital-raising transaction.
As advisors become familiar with management, operations, and the company’s growth strategy, some may independently decide to invest personal capital. At that point, the relationship changes. The individual is no longer acting solely as an advisor. The individual is also acting as a principal investor. That investment should be documented separately through a Stock Purchase Agreement and analyzed as a distinct securities transaction, typically under Section 4(a)(2) of the Securities Act and, where appropriate, Regulation D. Maintaining separation between the compensatory equity issuance. The investment transaction is critical because the two serve fundamentally different business and regulatory purposes.
The real power of the model emerges in the next step. Simultaneously with the initial investment, the investor may receive a second contractual investment right, documented through a separate Stock Purchase Agreement, investment option agreement, or SPA warrant. Unlike the initial SPA, which governs the current purchase of securities, the second agreement grants the investor the right, but not the obligation, to purchase additional securities in the future pursuant to predetermined pricing terms, exercise conditions, and timing requirements. The issuance of that right should itself be analyzed as a separate securities issuance, generally under the same private offering framework supporting the initial investment.
The economic rationale for the second SPA is what transforms the structure from a modest angel investment into a potential pathway toward a company’s first million dollars. Rather than asking an investor to commit a significant amount of capital on day one, the company asks for a smaller initial investment while preserving the investor’s ability to deploy substantially more capital later. The pricing mechanics for that future investment are negotiated at the outset, before the company has achieved many of the milestones expected to increase enterprise value. If management successfully executes its business plan during the intervening period, whether through customer growth, strategic partnerships, product development, revenue expansion, intellectual property creation, or other value-enhancing events, the investor may have the opportunity to make a substantially larger follow-on investment under economics established at an earlier stage of the company’s development.
From the investor’s perspective, the second SPA provides optionality. The investor gains additional time to evaluate execution while preserving access to a negotiated entry price. From the company’s perspective, the agreement creates a documented reservoir of potential future capital from stakeholders who already understand the business and are economically incentivized to support its growth. When replicated across multiple advisor-investors, the company may transform a relatively modest initial financing into a substantially larger pool of potential future capital commitments without immediately forcing investors to assume their maximum exposure.
The legal distinctions remain important throughout the structure. The NDA serves a confidentiality purpose. The advisory agreement governs services and compensatory equity. The initial SPA documents a current investment transaction. The second SPA creates a future investment right. Each instrument serves a separate business purpose, should be supported by independent corporate approvals and securities-law analysis, and should be documented as a separate transaction rather than collapsed into a single arrangement.
The true value of the Advisor-to-Investor Model is therefore not found in any individual agreement, but in the sequencing itself. The company first builds relationships, then creates engagement, then develops conviction, then secures investment, and finally establishes a contractual pathway toward larger future capital commitments. Properly structured, the model can help transform advisors into investors, investors into long-term capital partners, and a company’s earliest supporters into a practical bridge toward its first million dollars.
This article is for general informational purposes only and does not constitute legal, tax, accounting, investment, securities, or broker-dealer advice. The appropriate structure of any equity grant, option award, advisory arrangement, or investment transaction depends on the specific facts and circumstances, including applicable securities-law exemptions, tax considerations, valuation issues, jurisdictions, and regulatory requirements.
This publication is provided by Greenspoon Marder LLP is issued for informational purposes only and is not intended to be construed or used as general legal advice nor a solicitation of any type. Please contact the author(s) or your Greenspoon Marder LLP contact if you have any questions regarding the currency of this information. The hiring of a lawyer is an important decision. Before you decide, ask for written information about the lawyer’s legal qualifications and experience.